Form D · Pharmaceuticals
MANHATTAN PHARMACEUTICALS INC
New York, NY · CIK 0001001316
Offering snapshot reported Mar 26, 2012 · SEC filing
- Reported sold
- $11.1M Offering amount: $25M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Dec 30, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2012 | Initial | $11,091,426 | No comparison | 0 | SEC filing |
| Feb 29, 2012 | Amendment | $25,000,000 | $4,124,595vs Feb 22, 2012 | 416 | SEC filing |
| Feb 22, 2012 | Amendment | $20,875,405 | $18,327,905vs Mar 16, 2010 | 327 | SEC filing |
| Mar 16, 2010 | Initial | $2,547,500 | No comparison | 77 | SEC filing |
| Dec 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 12, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 12, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $25M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-175593
The offering includes securities to be acquired upon the exercise or exchange of other securities.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| NONE | None | National Securities Corporation · CRD 7569 |
Source: Form D, filed Mar 26, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas Abel | Director |
| Neil Herskowitz | Director |
| Michael Mc Guinness | Executive |
| Timothy Mc Inerney | Director |
| Sean Power | Executive |
| Richard Steinhart | Director |
| Michael Weiss | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
787 Seventh Avenue, 48 Th Floor Suite100
New York, NY, 10019
New York, NY, 10019